| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |